Literature DB >> 4421285

Distinct haematological disorder with deletion of long arm of no. 5 chromosome.

H Van den Berghe, J J Cassiman, G David, J P Fryns, J L Michaux, G Sokal.   

Abstract

Mesh：

Year:  1974        PMID： 4421285     DOI： 10.1038/251437a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  72 in total

Review 1.  Ribosome defects in disorders of erythropoiesis.

Authors:  Anupama Narla; Slater N Hurst; Benjamin L Ebert
Journal:  Int J Hematol       Date:  2011-02-01       Impact factor: 2.490

2.  Different boundaries characterize isolated and non-isolated 5q deletions in myelodysplastic syndromes and acute myeloid leukemias.

Authors:  Valeria Nofrini; Roberta La Starza; Barbara Crescenzi; Valentina Pierini; Gianluca Barba; Cristina Mecucci
Journal:  Haematologica       Date:  2012-02-13       Impact factor: 9.941

Review 3.  Molecular dissection of the 5q deletion in myelodysplastic syndrome.

Authors:  Benjamin L Ebert
Journal:  Semin Oncol       Date:  2011-10       Impact factor: 4.929

4.  The 5q- syndrome: biology and treatment.

Authors:  Eric Padron; Rami Komrokji; Alan F List
Journal:  Curr Treat Options Oncol       Date:  2011-12

5.  Two complex translocations in chronic granulocytic leukemia involving chromosomes 22, 9, and a third chromosome.

Authors:  P C Nowell; J Jensen; F Gardner
Journal:  Humangenetik       Date:  1975-10-20

6.  Myelodysplastic Syndrome with concomitant t(5;21)(q15;q22) and del(5)(q13q33): case report and review of literature.

Authors:  Anup Kasi Loknath Kumar; Brandon Weckbaugh; Christopher Sirridge; Janet Woodroof; Diane Persons; Suman Kambhampati
Journal:  Stem Cell Investig       Date:  2016-02-23

7.  Myelodysplasia: battle in the bone marrow.

Authors:  Yan Liu; Takashi Asai; Stephen D Nimer
Journal:  Nat Med       Date:  2010-01       Impact factor: 53.440

8.  Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients.

Authors:  Andrea Pellagatti; Martin Jädersten; Ann-Mari Forsblom; Helen Cattan; Birger Christensson; Emma K Emanuelsson; Mats Merup; Lars Nilsson; Jan Samuelsson; Birgitta Sander; James S Wainscoat; Jacqueline Boultwood; Eva Hellström-Lindberg
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-18       Impact factor: 11.205

Review 9.  Ribosomopathies: Old Concepts, New Controversies.

Authors:  Katherine I Farley-Barnes; Lisa M Ogawa; Susan J Baserga
Journal:  Trends Genet       Date:  2019-07-31       Impact factor: 11.639

10.  MMP9 inhibition increases erythropoiesis in RPS14-deficient del(5q) MDS models through suppression of TGF-β pathways.

Authors:  Minyoung Youn; Haigen Huang; Cheng Chen; Sharon Kam; Mark C Wilkes; Hee-Don Chae; Kunju J Sridhar; Peter L Greenberg; Bertil Glader; Anupama Narla; Shuo Lin; Kathleen M Sakamoto
Journal:  Blood Adv       Date:  2019-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.